Understanding in 2 Minutes: Brain Tumours

Comprendre en 2 minutes les tumeurs cérébrales

Professor Marc SANSON, Neurologist (AP-HP - Sorbonne University). Team leader at Paris Brain Institute, explains the causes, symptoms and treatments of brain tumours.

Pour en savoir plus

marquage multiplex de lymphocytes dans un échantillon de tumeur cerebrale

Les tumeurs cérébrales

Une tumeur est formée par des cellules qui se multiplient de façon incontrôlée, détournent à leur profit les cellules environnantes et peuvent, à des degrés divers perturber le fonctionnement du cerveau. Une tumeur cérébrale peut se développer dans n...

News that might interest you

Cellular senescence plays a significant role in cerebral tumors

Glioblastomas are the most common malignant tumors of the adult brain. They resist conventional treatment, including surgery, followed by radiation therapy and chemotherapy. Despite thisarmamentarium, glioblastomas inexorably recur. In a new study...

02.24.2023 Research, science & health

Gliome malin en culture cellulaire (spheroides).

Mechanisms and therapeutic implications of hypermutation in gliomas

A high tumour mutational burden (hypermutation) is observed in some gliomas 1, 2, 3, 4, 5; however, the mechanisms by which hypermutation develops and whether it predicts the response to immunotherapy are poorly understood.

04.28.2020 Research, science & health

Brain Tumours: ultrasound can increase the diffusion of the treatment

Teams from the Assistance Publique-Hôpitaux de Paris, the Pierre and Marie Curie University, the Inserm and the CarThera company, hosted at the Brain and Spine Institute (Institut du Cerveau - ICM), coordinated by professor Alexandre Carpentier...

06.16.2016 Research, science & health

Towards a more targeted therapy for brain tumors

Today, in France, about 5000 new carriers of malignant primary brain tumours are diagnosed each year. The symptoms depend on the localization of the tumour, its size and the rate at which it develops. Gliomas represent around 50-60% of all primary...

10.31.2014 Research, science & health

See all our news